Get started

Envision

Alternate name: Envision, Inc.
Country: US
Crossref ID: 100020841
DOI: 10.13039/100020841
OpenAlex ID: F4569576920
Simulation and experimental verification of prompt gamma-ray emissions during proton irradiation
2015 · A Schumann, J Petzoldt, et al. · Physics in Medicine and Biology · 25
PDF
Unimproved water sources and open defecation are associated with active trachoma in children in internally displaced persons camps in the Darfur States of Sudan
2019 · Colin K Macleod, Kamal Hashim Binnawi, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 21
PDF
Cloud gap-filling with deep learning for improved grassland monitoring
2024 · Iason Tsardanidis, Alkiviadis Koukos, et al. · Computers and Electronics in Agriculture · 15
Estimating background concentrations of PM2.5 for urban air quality modelling in a data poor environment
2023 · Eve L. Draper, J. Duncan Whyatt, et al. · Atmospheric Environment · 12
PDF
Lanadelumab’s impact on hereditary angioedema control and quality of life across disease activity subgroups
2025 · Andrea Zanichelli, Walter A. Wuillemin, et al. · Annals of Allergy Asthma & Immunology · 10
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial
2026 · Marcus Maurer, Marcin Stobiecki, et al. · The Lancet Haematology · 9
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial
2026 · Sophia Zoungas, David D’Alessio, et al. · The Lancet Diabetes & Endocrinology · 8
AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cancer
2025 · Jung-Yun Lee, Sathana Boonyapipat, et al. · Gynecologic Oncology · 8
Clinical evaluation of 4D PET motion compensation strategies for treatment verification in ion beam therapy
2016 · Chiara Gianoli, Christopher Kurz, et al. · Physics in Medicine and Biology · 7
Long-Term Safety of Vedolizumab in Patients With Ulcerative Colitis/Crohn’s Disease: A Prospective Observational Study
2025 · Edouard Louis, Shaji Sebastian, et al. · Clinical Gastroenterology and Hepatology · 6
Prevalence of trachoma in 13 Local Government Areas of Taraba State, Nigeria
2018 · Murtala M. Umar, Caleb Mpyet, et al. · Ophthalmic Epidemiology · 6
PDF
Ivosidenib or venetoclax combined with hypomethylating agents in IDH1-mutated acute myeloid leukemia: a real-world study
2025 · Curtis A. Lachowiez, B. Douglas Smith, et al. · Blood Neoplasia · 5
Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial
2026 · Georg Lenz, Marek Trněný, et al. · The Lancet · 4
Comparison of the enzymatic and cellular profiles of clinical JAK inhibitors for the treatment of myelofibrosis
2026 · Hamza Celik, Brittney Wass, et al. · Blood Neoplasia · 4
Are Microplastic (∼25–1000 μm) and Plasticizer Concentrations Correlated in Sediments of an Urbanized UK Estuary?
2025 · Alex Billings, Richard K. Cross, et al. · Environmental Science & Technology · 4
PDF
Anthropogenic Water Withdrawals Modify Freshwater Inorganic Carbon Fluxes across the United States
2025 · Elizabeth M. Flint, Matthew J. Ascott, et al. · Environmental Science & Technology · 4
Prevalence of Trachoma and Access to Water and Sanitation in Benue State, Nigeria: Results of 23 Population-Based Prevalence Surveys
2018 · Caleb Mpyet, Selassie Tagoh, et al. · Ophthalmic Epidemiology · 4
PDF
Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understanding
2026 · Victoria P. Werth, Lars Rönnblom, et al. · Frontiers in Immunology · 3
PDF
257 W/cm2 power-density laser-driven white-light source for high-speed inspection in semiconductor packaging
2025 · Seungjai Won, Taewon Kim, et al. · Optics and Lasers in Engineering · 3
Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader–Willi Syndrome: Results From the Randomized, Placebo-Controlled, Phase 3 COMPASS PWS Study
2026 · Elizabeth Roof, Theresa V. Strong, et al. · Clinical Therapeutics · 2
PDF
Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension Status
2026 · Ricardo Correa-Rotter, Peter Rossing, et al. · Kidney International Reports · 2
PDF
Design and rationale for the VICTRIVA study: A randomized, double-blind, phase 3b study of vedolizumab in combination with upadacitinib in Crohn's disease
2025 · Silvio Danese, Bruce E. Sands, et al. · Contemporary Clinical Trials Communications · 2
Impact of Hearing Impairment on Independent Travel in Individuals With Normal Vision, Low Vision, and Blindness
2025 · Philip Reed, Joseph Paul Nemargut, et al. · Trends in Hearing · 2
The Interruption of Transmission of Onchocerciasis in Abia, Anambra, Enugu, and Imo States, Nigeria: The Largest Global Onchocerciasis Stop-Treatment Decision to Date
2024 · Cephas Ityonzughul, Adamu Sallau, et al. · Pathogens · 2
Prevalence of Trachoma in Four Local Government Areas of Jigawa State, Nigeria
2018 · Caleb Mpyet, Nasiru Muhammad, et al. · Ophthalmic Epidemiology · 2
PDF
Works count: 45
Citation count: 174
H-index: 8
I10-index: 5
2-year mean citedness: 2.579
Awards count: 9
Year
Topic
Type